scholarly journals Comprehensive Analytical Methods of the Synthetic Cannabinoids Appearing In the Illicit Drug Market

2011 ◽  
Vol 16 (2) ◽  
pp. 73-90 ◽  
Author(s):  
Kei Zaitsu ◽  
Munehiro Katagi ◽  
Keiko Nakanishi ◽  
Noriaki Shima ◽  
Hiroe Kamata ◽  
...  
2012 ◽  
Vol 17 (2) ◽  
pp. E9-E9
Author(s):  
Kei Zaitsu ◽  
Munehiro Katagi ◽  
Keiko Nakanishi ◽  
Noriaki Shima ◽  
Hiroe Kamata ◽  
...  

Author(s):  
Mahmoud A. ElSohly ◽  
Sohail Ahmed ◽  
Shahbaz W. Gul ◽  
Waseem Gul

2021 ◽  
pp. 009145092110354
Author(s):  
Jennifer J. Carroll

Drug checking is an evidence-based strategy for overdose prevention that continues to operate (where it operates) in a legal “gray zone” due to the legal classification of some drug checking tools as drug paraphernalia—the purview of law enforcement, not public health. This article takes the emergence of fentanyl in the U.S. drug supply as a starting point for examining two closely related questions about drug checking and drug market expertise. First, how is the epistemic authority of law enforcement over the material realities of the drug market produced? Second, in the context of that authority, what are the socio-political implications of technologically advanced drug checking instruments in the hands of people who use drugs? The expertise that people who use drugs maintain about the nature of illicit drug market and how to navigate the illicit drug supply has long been discounted as untrustworthy, irrational, or otherwise invalid. Yet, increased access to drug checking tools has the potential to afford the knowledge produced by people who use drugs a technological validity it has never before enjoyed. In this article, I engage with theories of knowledge production and ontological standpoint from the field of science, technology, and society studies to examine how law enforcement produces and maintains epistemic authority over the illicit drug market and to explore how drug checking technologies enable new forms of knowledge production. I argue that drug checking be viewed as a form of social resistance against law enforcement’s epistemological authority and as a refuge against the harms produced by drug criminalization.


2020 ◽  
Author(s):  
Alexandra Voce ◽  
Tom Sullivan

This research investigates fentanyl use among police detainees participating in the Drug Use Monitoring in Australia program. Three percent of respondents tested positive to fentanyl and/or norfentanyl during urinalysis, and 11 percent reported lifetime fentanyl use. Nonprescribed fentanyl use was associated with use of and dependence on other drugs in the past 12 months. Three percent of all detainees believed they had used an illicit substance mixed with fentanyl. No detainees who tested positive to fentanyl reported using the drug in the past 12 months. These findings suggest fentanyl contamination may be occurring in the Australian illicit drug market.


Bioanalysis ◽  
2018 ◽  
Vol 10 (19) ◽  
pp. 1609-1623 ◽  
Author(s):  
Tiago Rosado ◽  
Joana Gonçalves ◽  
Ângelo Luís ◽  
Sara Malaca ◽  
Sofia Soares ◽  
...  

Author(s):  
Jarratt Pytell ◽  
Darius A. Rastegar

Tetrahydrocannabinol (THC) is the main psychoactive agent in the leaves of cannabis (marijuana) plants. Many synthetic cannabinoids have been recently developed. Cannabis is the most commonly used illicit drug in the United States; almost 20 million Americans currently consume cannabis. People who use cannabis may experience relaxation, euphoria, and mild hallucinogenic effects. Some may experience nausea and vomiting after use. Synthetic cannabinoids have been associated with more serious complications. Cessation after regular use may result in drug craving, insomnia, anorexia, and restlessness. Metabolites of THC can be detected in the urine up to 1 month after last use; some medications can cause false-positive tests. Serious medical complications of cannabis use are uncommon; the most concerning are neuropsychological problems among adolescent users and acute cognitive and motor impairment. Synthetic cannabinoid use is associated with significant neuropsychological effects. Psychosocial modalities appear to help those who wish to stop or reduce use. There are no medications that have been shown to be effective.


2017 ◽  
Vol 7 (1) ◽  
pp. 36-40 ◽  
Author(s):  
Harold E. Schueler

Hundreds of synthetic substances have been introduced into the illicit drug market over the last ten years, but none of these drugs has had as poisonous a consequence as the emergence of the synthetic fentanyl analogs. Initially, pharmaceutical grade or illicit fentanyl was mixed with heroin, allegedly to boost the potency of the heroin. Then, the amounts of fentanyl spiked gradually increased until the proportion of fentanyl was greater than the proportion of heroin. Ultimately, many overdose cases began consisting of only fentanyl. The emergence of numerous synthetic fentanyl analogs, including acetylfentanyl, butyrylfentanyl, acrylfentanyl, furanylfentanyl and β-hydroxythiofentanyl, which are manufactured in China, were made available to the illicit drug traffickers over the Internet. In July of 2016, the most potent commercially available opioid, carfentanil, started appearing in illicit drug submissions and medical examiner death investigation cases in Northeast Ohio. Postmortem femoral blood carfentanil concentrations are in the picogram per milliliter (pg/mL) range, which is extremely low, and tests the limits of detection for most analytical forensic toxicology laboratories. The interpretation of these low carfentanil blood concentrations in antemortem and postmortem specimens is made difficult due to the overlap in the concentrations between these specimen types. The presence of these powerful synthetic fentanyl analogs presents a challenge to forensic toxicology laboratories preparing to analyze for these substances.


Bioanalysis ◽  
2020 ◽  
Vol 12 (21) ◽  
pp. 1557-1595
Author(s):  
Ana Y Simão ◽  
Mónica Antunes ◽  
Hernâni Marques ◽  
Tiago Rosado ◽  
Sofia Soares ◽  
...  

One of the problems associated with the consumption of new psychoactive substances is that in most scenarios of acute toxicity the possibility of quick clinical action may be impaired because many screening methods are not responsive to them, and laboratories are not able to keep pace with the appearance of new substances. For these reasons, developing and validating new analytical methods is mandatory in order to efficiently face those problems, allowing laboratories to be one step ahead. The goal of this work is to perform a critical review regarding bionalytical methods that can be used for the determination of new psychoactive substances (phenylethylamines, cathinones, synthetic cannabinoids, opioids, benzodiazepines, etc), particularly concerning sample preparation techniques and associated analytical methods.


Sign in / Sign up

Export Citation Format

Share Document